skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Metastatic remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Phase II trial of humanized anti-Lewis Y monoclonal antibody for advanced hormone receptor-positive breast cancer that progressed following endocrine therapy
Phase II trial of humanized anti-Lewis Y monoclonal antibody for advanced hormone receptor-positive breast cancer that progressed following endocrine therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II trial of humanized anti-Lewis Y monoclonal antibody for advanced hormone receptor-positive breast cancer that progressed following endocrine therapy

Testa, Laura; Mano, Max; Arai, Roberto Jun; Bonadio, Renata Colombo; Serrano, Sergio V.; Zorzetto, Marina M Costa; Crocamo, Susanne; Smaletz, Oren; Freitas-Junior, Ruffo; Hoff, Paulo M.

Clinics; v. 76 (2021); e3146

Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo 2021-10-11

Acesso online

2
A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple‐negative breast cancer
A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple‐negative breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple‐negative breast cancer

Ho, Alice Y. ; Barker, Christopher A. ; Arnold, Brittany B. ; Powell, Simon N. ; Hu, Zishuo I. ; Gucalp, Ayca ; Lebron‐Zapata, Lizza ; Wen, Hannah Y. ; Kallman, Cindy ; D'Agnolo, Alessandro ; Zhang, Zhigang ; Flynn, Jessica ; Dunn, Samantha A. ; McArthur, Heather L.

Cancer, 2020-02, Vol.126 (4), p.850-860 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
3
Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma
Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma

Weiss, Glen J. ; Blaydorn, Lisa ; Beck, Julia ; Bornemann-Kolatzki, Kirsten ; Urnovitz, Howard ; Schütz, Ekkhard ; Khemka, Vivek

Investigational new drugs, 2018-02, Vol.36 (1), p.96-102 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
4
Genistein combined with FOLFOX or FOLFOX–Bevacizumab for the treatment of metastatic colorectal cancer: phase I/II pilot study
Genistein combined with FOLFOX or FOLFOX–Bevacizumab for the treatment of metastatic colorectal cancer: phase I/II pilot study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Genistein combined with FOLFOX or FOLFOX–Bevacizumab for the treatment of metastatic colorectal cancer: phase I/II pilot study

Pintova, Sofya ; Dharmupari, Sirish ; Moshier, Erin ; Zubizarreta, Nicole ; Ang, Celina ; Holcombe, Randall F.

Cancer chemotherapy and pharmacology, 2019-09, Vol.84 (3), p.591-598 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
5
Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma
Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma

Bahig, Houda ; Aubin, Francine ; Stagg, John ; Gologan, Olguta ; Ballivy, Olivier ; Bissada, Eric ; Nguyen-Tan, Felix-Phuc ; Soulières, Denis ; Guertin, Louis ; Filion, Edith ; Christopoulos, Apostolos ; Lambert, Louise ; Tehfe, Mustapha ; Ayad, Tareck ; Charpentier, Danielle ; Jamal, Rahima ; Wong, Philip

BMC cancer, 2019-01, Vol.19 (1), p.68-15, Article 68 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
6
Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study
Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study

Jespersen, Henrik ; Olofsson Bagge, Roger ; Ullenhag, Gustav ; Carneiro, Ana ; Helgadottir, Hildur ; Ljuslinder, Ingrid ; Levin, Max ; All-Eriksson, Charlotta ; Andersson, Bengt ; Stierner, Ulrika ; Nilsson, Lisa M ; Nilsson, Jonas A ; Ny, Lars

BMC cancer, 2019-05, Vol.19 (1), p.415-415, Article 415 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
7
Improving quality of life in patients with advanced cancer: Targeting metastatic bone pain
Improving quality of life in patients with advanced cancer: Targeting metastatic bone pain
Material Type:
Artigo 		Adicionar ao Meu Espaço

Improving quality of life in patients with advanced cancer: Targeting metastatic bone pain

von Moos, Roger ; Costa, Luis ; Ripamonti, Carla Ida ; Niepel, Daniela ; Santini, Daniele

European journal of cancer (1990), 2017-01, Vol.71, p.80-94 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
Material Type:
Artigo 		Adicionar ao Meu Espaço

Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

Yip, Steven M. ; Wells, Connor ; Moreira, Raphael ; Wong, Alex ; Srinivas, Sandy ; Beuselinck, Benoit ; Porta, Camillo ; Sim, Hao‐Wen ; Ernst, D. Scott ; Rini, Brian I. ; Yuasa, Takeshi ; Basappa, Naveen S. ; Kanesvaran, Ravindran ; Wood, Lori A. ; Canil, Christina ; Kapoor, Anil ; Fu, Simon Y.F. ; Choueiri, Toni K. ; Heng, Daniel Y.C.

Cancer, 2018-09, Vol.124 (18), p.3677-3683 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
9
Carcinoma of unknown primary (CUP): an update for histopathologists
Carcinoma of unknown primary (CUP): an update for histopathologists
Material Type:
Artigo 		Adicionar ao Meu Espaço

Carcinoma of unknown primary (CUP): an update for histopathologists

Beauchamp, Katie ; Moran, Bruce ; O’Brien, Timothy ; Brennan, Donal ; Crown, John ; Sheahan, Kieran ; Cotter, Maura Bríd

Cancer and metastasis reviews, 2023-12, Vol.42 (4), p.1189-1200 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
10
Pertuzumab, trastuzumab, and chemotherapy in HER2-positive gastric/gastroesophageal junction cancer: end-of-study analysis of the JACOB phase III randomized clinical trial
Pertuzumab, trastuzumab, and chemotherapy in HER2-positive gastric/gastroesophageal junction cancer: end-of-study analysis of the JACOB phase III randomized clinical trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pertuzumab, trastuzumab, and chemotherapy in HER2-positive gastric/gastroesophageal junction cancer: end-of-study analysis of the JACOB phase III randomized clinical trial

Tabernero, Josep ; Hoff, Paulo M. ; Shen, Lin ; Ohtsu, Atsushi ; Shah, Manish A. ; Siddiqui, Asna ; Heeson, Sarah ; Kiermaier, Astrid ; Macharia, Harrison ; Restuccia, Eleonora ; Kang, Yoon-Koo

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2023-01, Vol.26 (1), p.123-131 [Periódico revisado por pares]

Singapore: Springer Nature Singapore

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (158)
  2. Revistas revisadas por pares (159)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (171)
  2. Book Chapters  (2)
  3. Livros  (1)
  4. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2009  (10)
  2. 2009Até2012  (19)
  3. 2013Até2016  (38)
  4. 2017Até2021  (87)
  5. Após 2021  (21)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (170)
  2. Japonês  (19)
  3. Francês  (4)
  4. Português  (1)
  5. Mais opções open sub menu

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Mano, M
  2. Arai, R
  3. Zorzetto, M
  4. Smaletz, O
  5. Bonadio, R

Neste Assunto:

  1. Metastatic
  2. Metastatic
  3. Life Sciences & Biomedicine
  4. Science & Technology
  5. Oncology

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.